1
Clinical Trials associated with GA Depot(Mapi Pharma)A Phase III Study in Subjects With Relapsing Forms of Multiple Sclerosis (RMS) to Asses Efficacy, Safety and Tolerability of GA Depot, a Long Acting IM Injection of Glatiramer Acetate, Once Monthly Compared to Placebo
A multinational, multicenter, randomized, Phase III, double blind, parallel group, placebo controlled study in subjects with Relapsing Forms of Multiple Sclerosis (RMS) to assess the efficacy, safety and tolerability of GA Depot, a long acting IM injection of glatiramer acetate, administered once every four weeks
100 Clinical Results associated with GA Depot(Mapi Pharma)
100 Translational Medicine associated with GA Depot(Mapi Pharma)
100 Patents (Medical) associated with GA Depot(Mapi Pharma)
100 Deals associated with GA Depot(Mapi Pharma)